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1. Introduction 
Acanthamoeba keratitis (AK) infection is a rather frequently occurring disease all over the 
world which can still cause serious or even total loss of vision despite improved diagnostic 
and therapeutic options. It may cause mostly keratitis, scleritis or chorioretinitis in people 
with competent immune systems.  
It mainly affects contact lens wearers with poor hygiene. Corneal trauma due to foreign 
body injury and exposure to contaminated water may also be associated with Acanthamoeba 
infection. 
Those with Acanthamoeba keratitis generally are immunocompetent. Nevertheless, these 
individuals do not develop protective immunity, and thus reinfection can occur. In the mid 
1980s, an epidemic of Acanthamoeba keratitis occurred in the US which was attributed to 
increased contact lens use and poor lens hygiene. 
Conditions promoting the disease include not only poor contact lens hygiene but also the 
use of home-made saline solutions and corneal abrasions (Stehr-Green at al., 1989). 
In the United Kingdom, there was a marked rise in the number of cases in the first half of 
the 1990s, associated with the introduction and increasing popularity of disposable soft 
contact lenses shown to be due to irregular and/or chlorine based disinfection. After 1995 
there was a decrease, perhaps resulting from an improvement in CL hygiene following the 
widespread dissemination of the results of a paper on Acanthamoeba keratitis as well as the 
gaining penetrance of new CL hygiene systems (Radford et al., 1995, 1998, 2002). 
1.1 Features of Acanthamoeba 
Free-living amoebae belonging to the genus Acanthamoeba are the causative agents of 
granulomatosus amoebic encephalitis, a fatal disease of the central nervous system, 
cutaneous lesions and sinusitis in immonodeficient patients and amoebic keratitis, a painful 
sight-threatening disease of the eyes in otherwise healthy individuals. 
Acanthamoeba was first described by Castellani when he reported the presence of an amoeba 
in Cryptococcus pararoseus cultures. The genus Acanthamoeba was established later by 
Volkonsky in 1931 (Marciano-Cabral & Cabral, 2003). 
The first suggestion that Acanthamoeba could cause disease in humans came in 1958 during 
polio vaccine safety trials. Plaques appeared in cell cultures used to prepare vaccine and 
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were thought to be virus induced because mice and monkeys died from encephalitis 
following inoculation of tissue culture fluid. These observations of experimental animals 
dying from encephalitis led Culbertson et al. to predict a role for free-living amoebae as 
agents of human disease. Human cases of amoebic encephalitis were reported soon 
thereafter. The first cases which clearly established Acanthamoebae as causative agents of 
disease in humans were reported in the early 1970s with many more reports of various 
diseases following ever since (Dunand et al., 1997; Gulett et al., 1979; Illingworth & Cook 
1998; Jones et al., 1975; Martinez et al., 1994). 
Acanthamoeba spp. are among the most prevalent protozoa found in the environment. They 
are distributed worldwide and have been isolated from soil, dust, air, natural and treated 
water, seawater, swimming pools, sewage, sediments, air-conditioning units, drinking water 
treatment plants, bottled water, dental treatment units, hospitals and dialysis units, eyewash 
stations, and contact lenses and lens cases and as contaminants in bacterial, yeast, and 
mammalian cell cultures Acanthamoeba spp. also have been isolated from vegetation, from 
animals including fish, amphibia, reptiles, and mammals, from the nasal mucosa and throats 
of apparently healthy humans, from infected brain and lung tissue, from skin lesions of 
immunosuppressed patients, and from corneal tissue of patients with Acanthamoeba 
keratitis. It has been shown to live in domestic tap water pipelines especially in the cold 
water systems (Gray et al., 1995; Kilvington et al., 2004; Marciano-Cabral & Cabral, 2003; 
Radford et al., 1995). 
The life cycle of Acanthamoeba consists of two stages: an actively feeding, dividing 
trophozoite and a dormant cyst. The trophozoite varies in size from 25 to 40 µm and feeds 
on bacteria, algae, and yeast in the environment but can also exist axenically on nutrients in 
liquid taken up through pinocytosis. A double-walled wrinkled cyst composed of an 
ectocyst and an endocyst ranges in size from 13 to 20 µm and varies from species to species. 
Cyst formation occurs under adverse environmental conditions such as food deprivation, 
desiccation, and changes in temperature and pH. Cysts are resistant to biocides, 
chlorination, and antibiotics and survive low temperatures (0 to 2°C). But treatment with 
Freon or methylene oxide or autoclaving destroys cysts. Excystment occurs when 
trophozoites emerge from the cyst under suitable environmental conditions. It was 
demonstrated that cysts retained viable amoebae for over 24 years after storage in water at 
4°C (Khan, 2001; Marciano-Cabral & Cabral, 2003). 
The cellular organization of Acanthamoeba has been studied using electron microscopy. 
Organelles typically found in higher eukaryotic cells have been identified in Acanthamoebae. 
They have a Golgi complex, smooth and rough endoplasmic reticula, free ribosomes, 
digestive vacuoles, mitochondria, and microtubules in Acanthamoeba trophozoites. A 
trilaminar plasma membrane was found to surround the cytoplasmic contents of the 
trophozoite. In addition, distinguishing features of the trophozoite were the presence of 
spiny surface projections called acanthopodia, a prominent contractile vacuole in the 
cytoplasm that controls the water content of the cell, and a nucleus with a large central 
nucleolus. Generally, the amoebae are uninucleated, although multinucleated cells are 
common when Acanthamoeba are maintained in suspension culture. Reproduction occurs by 
binary fission (Marciano-Cabral & Cabral, 2003). 
Pathogenic Acanthamoeba exhibited higher numbers (above hundred) of acanthopodia as 
compared to non-pathogens (below twenty) (Khan, 2001). Acanthamoeba species can be 
assigned to three different groups on the basis of their cyst morphology. Later the complete 
gene sequence of nuclear small ribosomal subunit RNA was determined and using this 
approach, Acanthamoeba species was classified into 53 isolates on the basis of 12 rDNA 
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sequence types (RNA genotypes) designated typing units T1 to T12. Additional sequence 
types may exist. Sequences of either nuclear (RNA) or mitochondrial rRNA genes are 
suitable for classifying isolates. Current classification schemes integrate the morphological 
groups with the 12 sequence types (RNA genotypes) (T1 to T12) so that group I includes 
sequence types T7, T8, and T9, group II includes sequence types T3, T4, and T11, and group 
III includes sequence types T1, T2, T5, T6, T10, andT12. Studies in which clinical isolates 
have been identified based on sequence types have shown that the majority of strains 
causing keratitis belong to sequence type 4 (Marciano-Cabral & Cabral, 2003). 
Amoebae have been reported to exhibit different capabilities for binding and internalizing 
different species of bacteria. Bacterium amoebae interactions may lead to the establishment 
of an endosymbiotic state or, alternatively, to destruction of either the bacterium or the 
amoeba. The role of Acanthamoeba spp. as reservoirs or vectors for human pathogens has 
been examined. The intracellular growth of bacteria in Acanthamoeba has been associated 
with enhanced survival of bacteria in the environment, increased resistance of bacteria to 
biocides, and increased bacterial virulence. Intracellular survival within the amoebae has 
been postulated as a mode by which bacteria survive in substrate-limiting environmental 
ecosystems. Intracellular growth of bacteria in amoebae apparently also affects the 
resistance of bacteria to antibiotics (Marciano-Cabral & Cabral, 2003). 
1.2 Pathogenesis 
Pathogenic and nonpathogenic strains of Acanthamoebae have already been isolated from the 
environment, but the pathogenesis of infection and the biochemical determinants of 
virulence are poorly understood. Temperature tolerance, growth rate, adherence properties, 
cytolytic products produced by amoebae, and immune evasion mechanisms appear to 
constitute important factors in their pathogenicity. The virulence of pathogenic amoebae 
wanes during continuous culture in axenic medium but can be restored by brain passage in 
mice. It has been proposed that virulence may be related to distinct physiological 
characteristics of a strain and not to a dependence on environmental conditions (Marciano-
Cabral & Cabral, 2003). 
Animal studies have confirmed the clinical impression that contact lenses are vectors for 
transmitting trophozoites to the corneal surface and facilitating trophozoite binding to the 
corneal epithelium. Adherence of trophozoites to cells followed by injury and invasion of 
tissue are thought to represent important steps in the establishment of infections. Clinical 
isolates of A. polyphaga, A. castellanii, and A. culbertsoni have been shown to attach to corneal 
epithelial cells through a process which involves binding to cell surface carbohydrate moieties. 
A. castellanii binds to mannose containing glycoproteins on the corneal epithelium through a 
136-kDa mannose-binding protein on the amoeba surface. The adherence of Acanthamoeba to 
corneal epithelial cells can be inhibited by mannose and methylmannose pyranoside but not 
by other sugars (Clarke & Niederkorn, 2003; Hurt et al., 2003; Marciano-Cabral & Cabral, 
2003). Glycolipids of corneal epithelium reactive with Acanthamoeba may also play a role in the 
pathogenesis of Acanthamoeba keratitis by mediating the adherence of the amoebae to the 
cornea. Gordon et al., using binding assays, reported that Acanthamoeba binds preferentially to 
collagen IV, laminin, and fibronectin (Gordon et al., 1993).  
Following adherence to cells, invasion and extensive tissue destruction occur in the host. 
Human epithelial cells, stromal keratocytes, and stromal cell homogenates have been used 
in vitro as models of Acanthamoeba keratitis. Damage to cells and tissue is thought to occur 
by phagocytic processes and by cytotoxic substances released by amoebae. Exposure to 
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mannose induces Acanthamoeba trophozoites to produce a 133-kDa protease termed 
mannose-induced-protein (MIP) 133. MIP133 produces contact independent cytolysis of 
corneal epithelial cells in vitro. Corneal organ culture studies have shown that binding to 
mannose glycoproteins on the traumatized corneal epithelium induces trophozoites to 
release cytopathic factors (including MIP133) that facilitate corneal destruction and invasion. 
Activated MMPs degrade components of the basement membrane and the extracellular 
matrix, including types I and II collagens, fibronectin and laminin (Clarke & Niederkorn, 
2006; Hurt et al., 2003). Acanthamoeba trophozoites use multiple proteases with nonspecific 
collagenolytic activity to penetrate and degrade the stroma; these include serine proteases, 
cysteine protease, an elastase and a metalloproteinase. In addition, there is evidence that a 
collagenolytic enzyme could have a role in the generation of the ring-like stromal infiltrates 
and corneal lesions that are characteristic of Acanthamoeba keratitis. Trophozoite adherence 
was followed by penetration, a process which appeared to involve both secretion of lytic 
enzymes and phagocytosis (Clarke & Niederkorn, 2006; Hurt et al., 2003). 
1.3 Epidemiology, risk factors 
Acanthamoeba spp. are among the most prevalent protozoa found in the environment. This spp. 
are worldwide and could been isolated from different sites so as soil, dust, air, natural and 
treated water, seawater, swimming pools, domestic tap water, drinking water, or even bottled 
water. The number of Acanthamoeba in a freshwater lake bottom can be 200-2100 amoeba/g. 
In the Potomac River for example there was one amoeba per 3.4 L water. The highest 
percentage of pathogens is during spring and fall (Nwachuku & Gerba, 2004). Acanthamoebae 
have been detected in tap water and in swimming pools. In Mexico amoebae were found in 
13% of the water samples from faucets in private residences. In Egypt 2/50 tap water samples 
were contaminated. In Germany amoebae were found in 56% of hot water taps examined in 
hospitals. In England amoebae were isolated from bathroom and kitchen cold water taps. 
Amoebae may survive pool and spa disinfection (bromine, chlorine) procedures because of 
their resistant cyst stages. In 1977 Acanthamoebae were recovered in the water of 27 out of 30 
public pools. Acanthamoeba has been isolated in swimming pools in Germany, Mexico and in 
Norway, temperature-tolerant strains of Acanthamoeba in spas in New Zealand and Spain. 
Acanthamoeba was isolated from bottled water also in Mexico. Acanthamoeba cyst can be 
isolated from air, dust, air conditioner, cooling towers (Kilvington et al., 2004; Nwachuku & 
Gerba, 2004). Acanthamoebic keratitis first reported by Nagington et al. (Nagington et al., 
1974) in Great Britain and by Jones et al. Jones et al., 1975) in the United States is a painful 
progressive sight-threatening corneal disease. Since acanthamoebic keratitis is not a reportable 
disease, the true incidence is not known. Published works suggest an incidence rate of 0.58-
0.71 cases/1.000.000 in the general population, and 1.65-2.01/1.000.000 among contact lens 
wearers (Nwachuku & Gerba, 2004). The given incidence among contact lens wearers is 3-
5/1.000.000 in Holland, and 33/1.000.000 in Hong Kong (Seal, 2003). Three recent multi centre 
Questionnaire Reporting Surveys of Acanthamoeba keratitis were conducted in England 
within the past twenty years. The first in 1992–96 gave an incidence rate of 0.25 per 10 000 
contact lens wearers (CLW). The second and third surveys in England and Wales carried out 
in 1997–99 with one case in 47 620 CLW (or 0.21 per 10 000) and in 1998–99 with one case in  
555 CLW (or 0.18 per 10 000) found that 80% of all infections were manifest in lens wearers, 
with 88% using hydrogel lenses and 12% rigid lenses The incidence of acanthamoeba keratitis 
with gas permeable and rigid contact lenses is much lower than with soft hydrogel CL (Seal, 
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2003). In non contact lens wearers history of trauma in a garden is a risk factor (Radford et al., 
1998). 
Patient ages range from 4 to 64 years, with a mean age of 30 years, with no difference in 
genders (Radford et al., 1998; Sharma et al., 2000). Infection usually affects only one eye, 
although the infection is occasionally bilateral (Illingworth & Cook, 1998; Parthasarathy et 
al., 2007; Radford et al., 1998; Wilhelmus et al., 2008). Among non contact lens wearers 
trauma and exposure to contaminated water have been identified as major risk factors 
(Chynn et al., 1995; Sharma et al., 2000). Multivariable analysis showed that this is largely 
attributable to a lack of disinfection, the use of non-sterile saline, and the use of chlorine 
based disinfection rather than alternative chemical systems (Radford et al., 1995). Many CL 
users are still contaminating their contact lenses with tap water either directly (showering, 
face washing, handling with wet hands) or by using water to rinse their storage case 
(Radford et al., 2002; Seal et al., 1999). Disposable soft contact lenses seem to be a risk factor 
for contact lens induced keratitis. 89% of the patients with keratitis used this type of contact 
lens (Dejaco-Ruhswurm et al., 2001). It was shown that adherence of amoeba to the lens was 
higher among  disposable contact lenses (etafilcon A) than among the conventional lenses 
(polymacon) (Beattie et al., 2003, Lema et al., 2001). Attachment of Acanthamoeba was 
affected significantly by lens material type (P<0.001), with higher numbers of trophozoites 
attaching to the first-generation lotrafilcon A silicone hydrogel lens, compared with the 
second-generation galyfilcon A lens and the conventional hydrogel lens. Patient wear and 
the presence of a bacterial biofilm had no significant effect on the attachment to the 
lotrafilcon A lens but did significantly increase attachment to the galyfilcon A and the 
etafilcon A (P = 0.009) lenses. If exposed to Acanthamoeba (e.g., when showering or 
swimming, through non-continuous wear and ineffective lens care regimes), first-generation 
silicone hydrogel lenses may promote a greater risk of Acanthamoeba infection due to the 
enhanced attachment characteristics of this lens material (Beattie et al., 2006). 
An initial coinfection occurs, with the bacteria providing an additional food source for the 
amoebae. The presence of bacterial biofilm may also affect amoebal sensitivity to 
disinfectants (Illingworth & Cook, 1998). 
Trophozoite and cyst adherence of two acanthamoeba keratitis strains to four types of 
unworn soft contact lens and their removal by cleaning agents were studied. Greater 
adherence of the trophozoites compared with the cysts was recorded. Trophozoites adhered 
in greater numbers to type I lenses (poly2-hydroxyethyl methacrylate), with no differences 
between type II (lidofilcon A), III (bufilcon A) and IV (etafilcon A) lenses. Adherence of the 
other trophozoites to type II lenses was lower compared with their adherence to the other 
lenses. Cysts of both strains showed greater adherence to type I and III lenses. 
Recommended cleaning procedures using three commercial solutions were effective in 
removing Acanthamoeba from the lenses (Kilvington, 1993). 
1.4 Clinical symptoms 
The clinical picture of acanthamoeba keratitis is remarkable for its varied manifestations, 
although these often seem to occur in a recognizable sequence. Most patients complain of 
symptoms of photophobia, pain, and tearing. The pain in acanthamoeba keratitis may be 
particularly severe, seemingly disproportionate to the signs, although the absence of severe 
pain does not preclude the diagnosis. Rarely, there may be an apparent precipitating event, 
such as an injury to the eye, swimming while wearing lenses, or insertion of a non-sterile 
lens. Symptoms may continue uninterrupted from the time of an injury, sometimes with 
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apparent failure of a corneal abrasion to heal, or rarely, there may be a delay of up to 2 
weeks before the onset of symptoms. The earliest signs may be non-specific and may take 
the form of epithelial micro erosions, irregularities, opacities or microcystic oedema, often 
with patchy anterior stromal infiltrates. There may be no fluorescein staining at the onset. 
Commonly, there is a dendriform keratitis that is often initially treated as herpes simplex 
infection. Limbitis (limbal hyperaemia and oedema) is a very frequent finding in both early 
as well as late stages of the disease. A pattern of perineural infiltrates that occurs in a radial 
distribution (radial keratoneuritis) is virtually pathognomic for acanthamoeba keratitis. A 
ring infiltrate, usually with an overlying epithelial defect is commonly seen. Although 
initially the epithelium within the ring may be intact, in longstanding cases a central defect, 
which is often associated with stromal thinning, may occur. The ring may be incomplete, or 
occasionally it is double and concentric. The inflammation may involve the sclera, evidence 
of direct scleral invasion by amoebae has often been elusive, leading to the conclusion that 
scleritis is a secondary immunologic reaction. Posterior segment signs are rare, although 
occasional reports of optic nerve oedema, optic neuropathy and optic atrophy, retinal 
detachment, choroidal inflammation, and formation of a macular scar exist. Contra lateral 
chorioretinitis has also been observed. In up to 20% of cases cataract may occur, although 
this appears to be associated with severe or prolonged inflammation, and use of topical 
corticosteroids. Glaucoma is commonly reported, particularly in advanced stages 
(Illingworth & Cook, 1998; Radford et al., 1998; Reinhard & Sundmacher, 2000). 
1.5 Diagnosis 
The importance of early diagnosis cannot be overemphasized. We have to consider 
acanthamoeba keratitis when symptoms associated with trauma especially involving 
vegetable matter or exposure to contaminated water, such as lake -, sea-, or spring water are 
mentioned. Early diagnosis is essential to ensure a good prognosis. If effective therapy is 
delayed for 3 or more weeks the prognosis will deteriorate. Acanthamoeba keratitis should 
be considered in any case of corneal trauma complicated by exposure to soil or 
contaminated water, and in all CL wearers (Dart et al., 2009). We also have to question the 
patients about this during the history taking. 
Acanthamoebic keratitis has to be differentiated from bacterial or fungal or herpes simplex  
virus (HSV) keratitis. In addition, the disease must be considered when there is a failure to 
respond to first-line therapy for bacterial or herpes simplex virus keratitis, even when there 
has been a positive culture for another organism, because 10% to 23% of cases of 
Acanthamoeba keratitis may be polymicrobial or co-infected. Perineural and/or ring 
infiltrates are characteristic clinical signs of the disease (Dart et al., 2009; Marciano-Cabral & 
Cabral, 2003; Radford et al., 1998). 
Diagnosis may be achieved by using different methods, including non invasive confocal 
microscopy which is the preferred diagnostic technique in some centres, with sensitivity and 
specificity exceeding 90% (Dart et al., 2009). Another quick method is staining corneal 
scrapings with acridine orange, which reveal yellow-to-orange polygonal, cystic structures 
consistent with the appearance of Acanthamoeba among inflammatory cells and the corneal 
epithelial cells (Hahn et al., 1998). An additional advantage of the method is that no special 
solutions and staining techniques are required. A definitive diagnosis of Acanthamoeba 
keratitis can only be made on the basis of culture or histology, or by the identification of the 
presence of amoebic DNA with PCR (Dart et al., 2009). Corneal scrapes or corneal biopsy 
specimens are used for culture or for the identification of cysts or trophozoites in stained 
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tissue sections. For culture, material from a corneal scrape can be placed onto no nutrient 
agar containing E. coli. It should be incubated at 28 to 35°C and held for an extended interval 
(10 days or more to ensure time for excystation) because some species of Acanthamoeba do 
not grow well at 35°C or above. However, corneal scrapes may contain bacteria or yeast, 
which can confuse the diagnosis. Corneal biopsy has been suggested when repeated 
cultures of corneal scrapings are negative (Illingworth & Cook, 1998; Marciano-Cabral & 
Cabral, 2003). For a cytological diagnosis, various staining methods can be employed. The 
indirect immunofluorescent-antibody assay has been used to detect amoebae in corneal 
scrapings or in biopsy tissue. Calcofluor white, a chemo fluorescent dye with an affinity for 
the polysaccharide polymers of amoebic cysts, has been used to identify amoebic cysts in 
corneal tissue. Calcofluor white stains amoebic cyst walls bright apple green and this effect 
can be enhanced by prolonging the staining period. Evans blue is used to counter stain the 
background. Trophozoites and cysts in paraffin-embedded tissues can also be rapidly and 
differentially stained with calcofluor white (Marciano-Cabral & Cabral, 2003). For the rapid 
and sensitive identification of Acanthamoeba at the genus level, a polymerase chain reaction 
(PCR)-based method can be used. For typing Acanthamoeba isolates a restriction fragment 
length polymorphisms (RFLPs) is useful (Khan et al., 2001; Kilvington et al., 2004). 
1.6 Treatment 
The goals of medical therapy in Acanthamoeba keratitis include the eradication of viable 
cysts and trophozoites and rapid resolution of the associated inflammatory response.  
1.6.1 Medical treatment 
There is no single drug capable of eliminating the infection therefore drug combinations have 
been suggested as a treatment regimen. Several drugs are known to be amoebicid and cysticid.   
There are currently no drugs that are effective as monoterapy in Acanthamoeba keratitis, so 
combinations are suggested. Acanthamoeba trophozoites are sensitive to most available 
chemotherapeutic agents (antibiotics, antiseptics, antifungals, antiprotozoals including 
metronidazole, antiviral, and antineoplastic agents). However, persistent infection is related 
to the presence of Acanthamoeba cysts, against which very few of these agents have any effect 
and only agents that are cysticidal in vitro against cysts can be expected to be effective as 
therapy. The diamidines and biguanides are currently the most effective cysticidal 
antiamoebics in vitro and their use is supported by substantial case series. Metronidazole 
(Flagyl; Pfizer Inc, New York, New York, USA) has been used for several cases in one series, 
but has proved to have no effect in vitro. For these reasons topical therapy with biguanides 
with or without the addition of diamidines is currently the mainstay of treatment for 
Acanthamoeba keratitis (Bacon et al., 1993; Dart et al., 2009; Illingworth et al., 1995; 
Illingworth & Cook, 1998; McCellan et al., 2001; Seal, 2003). 
Biguanides: The two biguanides that are in use are polyhexamethylene biguanide (PHMB) 
0.02% to 0.06% (200 to 600 g/ml) and chlorhexidine 0.02% to 0.2% (200 to 2000 g/ml). The 
biguanides interact with the cytoplasmic membrane, resulting in loss of cellular components 
and inhibition of respiratory enzymes. Both drugs have been effective clinically as primary 
therapy, as well as in cases where other agents have failed. Clinically, corneal epithelial 
toxicity has been minimal for both chlorhexidine 0.02% and PHMB 0.02%. Biguanides can be 
used as first-line treatment for Acanthamoeba keratitis either alone or in combination with 
diamidines, with which there may be a synergistic or additive effect (Bacon et al., 1993; Dart 
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et al., 2009; Illingworth et al., 1995; Illingworth & Cook, 1998; McCellan et al., 2001; Seal, 
2003). 
Diamidines. Available diamidines include propamidine isethionate 0.1% (1000 g/ml) and 
hexamidine 0.1% (1000 g/ml); these are licensed as antibacterials in some European 
countries. The antimicrobial effects of the diamidines result from the cationic surface-active 
properties inducing structural membrane changes affecting cell permeability. When these 
molecules penetrate into the amoebic cytoplasm, denaturation of cytoplasmic proteins and 
enzymes occurs. Propamidine and hexamidine have been effective clinically against both 
the trophozoite and cyst forms of Acanthamoeba. Clinically, the diamidines are well tolerated 
by ocular tissues, although prolonged treatment with propamidine may lead to toxic 
keratopathy (Bacon et al., 1993; Dart et al., 2009; Illingworth et al., 1995; Illingworth & Cook, 
1998; McCellan et al., 2001; Seal, 2003). 
Although neomycin has been widely used, it is ineffective against cysts in vitro. In addition, 
like all aminoglycosides it is toxic to the corneal epithelium and can often result in indolent 
corneal ulceration that may be incorrectly attributed to disease activity, nevertheless it is 
effective for the bacterial co-infection. Povidon-Iodine (Betadine) is amoebicid and cysticid 
generally, however it can be used in 0.5% concentrate as well (Bacon et al., 1993; Dart et al., 
2009; Illingworth et al., 1995; Illingworth & Cook, 1998; McCellan et al., 2001; Seal, 2003). 
Topical corticosteroids. The role of steroids is controversial, but we believe that topical 
corticosteroids can have an important and beneficial role in the management of some cases 
of Acanthamoeba keratitis. The dead cysts persist in the corneal stroma and remain 
antigenic. This can give rise to a serious inflammatory reaction. Steroid treatment is 
unnecessary in most cases diagnosed early, which usually respond rapidly to antiamoebic 
drugs. However, persisting inflammation (anterior scleritis, severe pain, indolent ulcers, 
corneal inflammation, and anterior chamber inflammation) may respond dramatically to the 
addition of even low-potency topical steroid therapy, e.g. prednisolone 0.5%, or 
dexamethasone 0.1% 4 times daily.  Clinicians should be careful to avoid use of 
corticosteroids if possible because they suppress the activity of the macrophage, which is the 
‘scavenger’ phagocytic cell responsible for host immunity to Acanthamoeba. Use of 
nonsteroidal anti-inflammatory drugs, particularly flurbiprofen, is encouraged and also acts 
as both an analgesic and a mydriatic. When attendant to the inflammation secondary 
glaucoma appears, anti-glaucomatic drops are used. Pupil dilatators are also used for 
moving the pupil (Bacon et al., 1993; Dart et al., 2009; Illingworth et al., 1995; Illingworth & 
Cook, 1998; McCellan et al., 2001; Seal, 2003).  
1.6.2 Surgical treatment 
With respect to the severity of the disease as well as the complications accompanying it there is 
a range of surgical methods to choose from. 
Corneal abrasion or debridement of the affected area of corneal epithelium may be successful if 
performed at an early stage. Repeated debridement is used in some centres to improve drug 
penetration (Dart et al., 2009; Illingworth & Cook, 1998; Reinhard & Sundmacher, 2000). 
Cryosurgery may be valuable in treating Acanthamoeba keratitis cases. Cryocoagulation to 
the ring infiltrate and central cornea breaks the infected cells and cyst walls (Amoils & 
Heney, 1999; Reinhard & Sundmacher, 2000). 
Deep lamellar keratectomy with a conjunctival flap is a suitable approach to help control the 
infection and to help relieve pain in patients with advanced Acanthamoeba keratitis 
(Cremon et al., 2002; Parthasarathy & Tan, 2007). 
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Instead of conjunctiva, amniotic membrane is usable. This suggests that amnion cells in 
amniotic membrane release proteinase inhibitors and that stromal matrix selectively provide 
adhesion molecules for polymorphonuclear cells (Kim et al., 2000). Amniotic membrane 
transplantation may be a safe and effective treatment of severe Acanthamoeba keratitis, 
particularly during the inflammation phase. It may permit penetrating keratoplasty to be 
delayed (Bourcier et al., 2004). 
The role of keratoplasty is now largely restricted to the visual rehabilitation of eyes in which a 
medical cure has been achieved. In advanced cases corneal transplantation may be 
necessary. Because of use of antiamoebal agents, penetrating keratoplasty is now usually 
unnecessary in the acute phase unless the cornea has become very thin, with consequent risk 
of perforation (Bacon et al, 1993; Dart et al., 2009; Illingworth & Cook, 1998; Reinhard &  
Sundmacher, 2000). 
Deep lamellar keratoplasty (DLK) with total removal of infected stromal tissue may be 
performed in medically unresponsive cases of Acanthamoeba keratitis. Advantages of 
DLK in infectious keratitis include less risk of intraocular entry of infectious organisms at 
the time of surgery and the potential for improved graft survival rates caused by less 
endothelial rejection and failure. In patients with severe disease involving the visual axis, 
earlier surgery with DLK would allow debulking of the organisms as well as preservation 
of autogenous endothelial cell function (Parthasarathy & Tan, 2007; Por et al., 2009; 
Taenaka et al., 2007). 
In some cases enucleation or evisceration is needed, because of inflammation, infection or 
secundary glaucoma (Bacon et al., 1993; Radford et al., 1998; Reinhard & Sundmacher, 
2000). 
2. Mean headings 
2.1 Patients, methods and results 
Patients’ features and clinical data are summarised in Table 1. 
 
pati- 
ent 
age sex time till 
diagnosis 
BCV
A  
diagnosis clinical 
features 
medical 
treatment 
keratoplasty surgical 
treatment 
BCVA 
at latest 
follow up 
1. 25 female 3 days 0.01 corneal 
scrape 
corneal 
ulcus 
dimopropamide
+neomycine 
+ciprofloxacin 
+diclofenac 
+cyclopentholat
after 2 years 
urgency 
keratoplasty 
(7.75/8.0 mm)
because 
descemetocele
aspiration 
lentis, scleral 
buckling, 
vitrectomy 
light 
perceptio
n 
2. 26 female 2 weeks 0.01 clinical 
findings 
central 
ring-
infiltratio
n 
dimopropamide
+PHMB 
+neomycine 
+ciprofloxacin 
+prednisolon 
+atropin 
+cyclopentholat
after 3 month 
proposed 
keratoplasty 
(7.0/7.25 mm)
 0.7 
3. 41 female 4 weeks 0.03 histology central 
corneal 
ulcus, 
hypopyon
dimopropamide
+PHMB 
+neomycine 
+ciprofloxacin 
+diclofenac 
after 4 month 
proposed 
keratoplasty 
(7.0/7.75 mm) 
 1.0 
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pati- 
ent 
age sex time till 
diagnosis 
BCV
A  
diagnosis clinical 
features 
medical 
treatment 
keratoplasty surgical 
treatment 
BCVA 
at latest 
follow up 
4. 23 male 4 weeks 0.02 corneal 
scrape 
central 
corneal 
abscess 
dimopropamide
+PHMB 
+neomycine 
+ciprofloxacin 
+diclofenac 
+timolol 
after 1 month 
urgency 
keratoplasty 
(7.0/7.5 mm) 
 light 
perception 
5. 33 female 4 weeks 0.02 histology central 
infiltration
dimopropamide
+neomycine 
+fluorometholon
+cyclopentholat
after 6 month 
urgency 
keratoplasty 
(7.5/7.5 mm) 
corneal 
abrasion, 
phaco- 
emulsifikation
+IOL 
0.9 
6. 65 female 2 months 0.15 clinical 
findings 
central 
ring-
infiltration
dimopropamide
+PHMB 
+neomycine 
+ciprofloxacin 
+diclofenac 
after 2 years 
urgency 
keratoplasty 
(7.7/8.25 mm)
ECCE+PCL+ 
trabeculectomy 
after 1 year 
light 
perception 
Table 1. Clinical data of our patients (BCVA=best corrected visual acuity) 
2.1.1 Demographics 
Between 2001 and 2006 we treated 11 patients with Acanthamoeba keratitis. The mean age 
of the patients was 30.2 years (16-65). The eight female and three male patients were all soft 
contact lens wearers. The right eye was affected in six and the left in five cases. 82% of the 
infections occurred in the summer period between June and September. The appropriate 
diagnosis of Acanthamoeba keratitis took 3 days to 2 months. Beside long-lasting 
conservative treatment perforating keratoplasty was performed in six cases. In the following 
we discuss these patients in details. 
2.1.2 Risk factors 
The infection was caused by poor and improper contact lens hygiene in each and every case. 
All lenses involved were hydrogel soft lenses: 1 daily, 4 monthly and 1 yearly disposable. 
None of the lenses have been applied for extended or continuous wear. Two patients rinsed 
the lenses in tap water, 4 patients went to swim in them. The half of the patients got the 
lenses from opticians, the other half from ophthalmologists. 
2.1.3 Clinical findings and diagnosis 
Significant visual decrease (0.15-0.01) was seen in almost all cases. Slit lamp examination 
showed corneal infiltration in 2 cases, ring infiltration (Fig. 1. and 2.) in 3 cases and corneal 
abscess in 1 case. The diagnosis was based on corneal scraping in 2 cases, on histology in 2 
cases, and on clinical findings in 2 cases.   
2.1.4 Medical treatment 
Treatment started with antiamoebic agents in all patients: dibromopropamide or propamidin 
and polihexamethilen biguanidine was administerd hourly in the first week, and then 5 
times/day for at least 6 months. All patients were administered antibiotic drops 5 times a day 
for 2 weeks. Two patients had to use antiglaucomatic drops because of secondary glaucoma. 
We used steroid or non-steroid agents against the inflammation in seven cases.  
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Fig. 1. Anterior segment of patient No 5 before keratoplasty with  corneal abscess 
 
 
 
Fig. 2. Corneal scar of patient No 2 before optical keratoplasty 
www.intechopen.com
 
Keratoplasties – Surgical Techniques and Complications 
 
42
2.1.5 Indications for surgical intervention 
In one case we performed corneal abrasion, but as it proved ineffective we followed it up 
with perforating keratoplasty.  
Perforating keratoplasty was performed in six cases. In four cases keratoplasty was 
performed as an emergency to save the eyeball (because of descemetocele), in two cases the 
operations were scheduled for visual rehabilitation. The emergency cases were the “late 
diagnostic” cases. 
Shape and size of keratoplasty and surgical techniques: All keratoplasties were perforating 
(penetrating), and central. All surgical procedures were done by two experienced surgeons. 
All cases were performed under retrobulbar anaesthesia. The trephination was performed 
with modified Geuder trephines for the host cornea from the epithelial side, and the graft 
from the endothelial side. Donor corneas were from the Eye Bank of our department. Only 
grafts with an endothelial cell count above 2000 cells/mm² were used. The mean graft 
diameter was 7.7 mm (range 7.25 to 8.25 mm), with an average over sizing of 0.5 mm. Graft 
fixation was performed in all cases with running nylon 10/0 sutures. (Fig. 3.,4.) 
2.1.6 Postoperative management 
Topical antibiotic and steroid drops were used five times a day for 6 weeks, then only 
steroid drops for 6 months. Anti amoebatic drops 5 times/day for at least six months.  
2.1.7 Complications 
We have had no intraoperative complications. Postoperative glaucoma appeared in 2 cases, 
in one case trabeculectomy was performed. In 3 cases cataract operation was necessary after 
some months. In one case retinal detachment developed and therefore scleral buckling 
operation was needed. 
 
 
Fig. 3. Postoperative status of perforated keratoplasty of patient No 5.  
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Fig. 4. Early postoperative status of patient No 2.  
2.1.8 Graft clarity and visual acuity 
At the last follow up visit the visual acuity was 0.43. In 3 cases it was only light perception, 
but the other 3 patients had very good visual acuity (0.7-1.0). 
In the emergency cases the visual acuity was much worse (light perception in 3 cases and 0.9 
in one case), then in the proposed cases (0.7 and 1.0). In 5 cases the cornea graft was clear, 
rejection and decompensation developed only in one case.  
2.2 Corneal graft surgery/keratoplasty 
2.2.1 Emergency keratoplasty 
Emergency keratoplasty or keratoplasty à chaud is often the only possible intervention to 
prevent complete and irreversible vision loss in patients with severe corneal disorders. The 
main indications for this urgent surgical procedure are corneal perforations or imminent 
perforations, maintaining the integrity of the globe, as well as persisting infectious keratitis. 
Due to acute inflammation of the anterior ocular segment, emergency keratoplasty is 
supposed to have a worse outcome and more postoperative complications especially more 
immune reactions than scheduled keratoplasty. Keratoplasty for management of the acute 
complications of Acanthamoeba keratitis has with few exceptions in small numbers of 
patients (Illingworth & Cook, 1998; Nguyen et al., 2010; Maier et al., 2007; Shi et al., 2009), 
generally been reported to have poor results. Graft failure due to recurrent infection is 
common when keratoplasty is performed in an inflamed eye. In most cases, however, 
keratoplasty has been successful in maintaining the integrity of the globe, and a second 
procedure has often resulted in a good visual outcome (Illingworth & Cook, 1998; Maier et 
al., 2007). 
www.intechopen.com
 
Keratoplasties – Surgical Techniques and Complications 
 
44
Since the introduction of the biguanides as medical therapy, PK has not been recommended 
as a treatment for the elimination of organisms; emergency keratoplasty should therefore be 
reserved as a treatment for corneal perforation, imminent perforation and fulminant corneal 
abscess. Many of these eyes will be severely inflamed with uncontrolled scleritis and 
limbitis, which should be treated before surgery with systemic immunsuppression using 
prednisolone (0.5 to 1 mg/kg/day) and/or cyclosporine (3 to 7.5 mg/kg/day), which is 
tapered as inflammation is controlled in the post graft period (Dart et al. 2009; Maier et al., 
2007). Performing PK before scleral or peripheral corneal extension can minimize the risk of 
recurrence and poor outcome (Nguyen et al., 2010; Tanhehco & Colby, 2010). 
2.2.2 Therapeutic/optical keratoplasty 
Several authors (Awwad et al., 2005; Por et al., 2009) recommend observing for at least 3 
months of clinical inactivity after completion of antiamoebic therapy before attempting PK. 
Most recently, Kitzmann et al. (Kitzmann et al., 2009) compared outcomes of 22 eyes with 
Acanthamoeba keratitis undergoing emergency penetrating or anterior lamellar keratoplasty 
and 9 eyes undergoing optical penetrating or anterior lamellar keratoplasty. Although all eyes 
ultimately achieved microbiological cure, there was a 41% recurrence rate of Acanthamoeba 
keratitis after emergency keratoplasty compared with 22% recurrence rate after optical 
keratoplasty. The Kaplan–Meier graft survival was 37.5% (95% confidence interval, 16.8–58.4) 
at 5 years in the therapeutic group compared with 100% in the optical group. Shi et al. (Shi et 
al., 2009) reported 28% recurrence after emergency PK. For acanthamoeba keratitis, Ficker et al. 
(Ficker et al., 1993) found that clear graft survival was only 20% if penetrating keratoplasty 
was performed during the acute, inflamed state of the disease compared to 100% clear graft 
survival when penetrating keratoplasty was performed in a quiet state of the disease. The 
reason for the difference compared to other results might possibly be differences in case 
selection at the time of diagnosis, preoperative treatment and the time point of the decision for 
emergency keratoplasty seem to be most important for the outcome of the graft (Maier et al., 
2007). Dart et al. (Dart et al., 2009) present cases, when therapeutic keratoplasty is rarely used 
but lamellar or PK to improve vision is carried out in patients with scarred corneas and/or 
irregular astigmatism. The outcome of corneal transplantation is good in this group of 
patients. Exacerbations of scleritis and limbitis may occur following graft surgery in these eyes 
and may need to be treated with systemic anti-inflammatory treatment (Dart et al., 2009). 
Quian et al. (Qian et al., 2010) performed 8 optical perforating keratoplasty after at least 4 
months medical treatment, with great success. Awwad et al. (Awwad et al., 2005) published an 
article about 13 eyes which underwent optical PK for visual rehabilitation after acanthamoeba 
keratitis. They mean that PK for visual restoration after resolution of Acanthamoeba keratitis in 
quiet eyes that are judged cyst-free by preoperative confocal microscopy appears to have an 
excellent long-term prognosis. Waiting at least 3 months after the discontinuation of medical 
therapy also appears helpful to rule out latent infection because of cyst reactivation and to 
allow the active inflammation to cease.  
The success of keratoplasty in the literature are summarised in Table 2.  
2.2.3 Donor size 
The extent of the infected corneal tissue cannot be identified and should be assumed to 
include the entire cornea so that, unlike grafts for other corneal infections, which should be 
large enough to remove all contaminated tissue, the graft for Acanthamoeba keratitis should 
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author year total acute success % optical success % 
Kitzmann 2009 30 22 45.5 8 100 
Nguyen 2010 9 9 100   
Ficker 1993 13 7 20 6 100 
Maier 2007 13 13 73   
Kashiwabuchi 2008 32 32 43.8   
Awwad 2005 13   13 100 
Tanhehco 2010 8 8 50   
Qian 2010 8   8 100 
Por 2009 15 12  3  
Illengworth 1995 9 9 100   
Bacon 1993 34 21 35 13 69 
Radford 1998 31     
Sharma 2000 3 3 0   
Table 2. Success rate of keratoplasty 
be kept to the minimum size required to excise all ulcerated and necrotic tissue, retaining 
clinically healthy (but usually subclinically infected) tissue. This is because of the risk of 
rejection with large grafts and because repeating grafting may be needed as a result of 
recurrence; a further graft represents a new food source for the organism and can be used to 
attract residual amoebae. Recurrence of disease in a graft was frequent in the first 2 weeks 
after surgery when keratoplasty was performed in an inflamed eye before the introduction 
of biguanides; it typically involved the donor periphery, usually without clinical 
involvement of the host. Late recurrences, several months after surgery, may also occur. The 
use of large grafts worsens the prognosis because it increases the chances of an immune 
response to the graft. Furthermore, the use of a large graft indicates a more severe 
preoperative infection (Ficker et al., 1993). 
Host trephination size ranged from 7 to 11 mm depending on the extent of the corneal 
infiltration. The trephination should be performed beyond the clinical areas of infiltrate, 
including satellite lesions. Confocal microscopy can be used to outline the extent of 
involvement or the size of the trephination (Kashiwabuchiet al., 2008; Nguyen et al., 2010). 
Meier et al. reported about a trend toward improved clear graft survival and fewer immune 
reactions following emergency keratoplasty using smaller grafts (≤8.00 mm) (Awwad et al., 
2005; Maier et al., 2007). 
Ideally, a corneal scar should be debulked as much as possible because residual cysts 
might still be present and might lead potentially to a recurrence of the disease when 
exposed to topical corticosteroids after PK. In those cases, rather than jeopardizing graft 
survival by trephining a large donor button (sizes of 9 mm and beyond), we suggest 
waiting for a longer period of time after the discontinuation of medical treatment, with 
repetitive confocal examination when available, before committing the patient to surgery 
(Awwad et al, 2005). 
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3. Prevention 
Acanthamoeba keratitis is a potentially blinding condition of the eye, and any steps toward 
prevention of this disease are encouraged. It is recommended contact lens wearers to use 
daily disposable contact lenses to eliminate the contact lens case as a reservoir for 
Acanthamoeba. If daily disposable contact lens can not be used, then hydrogen peroxide 
cleaning solutions are preferred over the more common multipurpose solutions because of 
the increased efficacy of hydrogen peroxide against Acanthamoeba cysts. Planned 
replacement of contact lens storage cases may also help reduce contamination. It is 
important for eye care professionals not only to emphasize proper contact lens wear and 
hygiene in the prevention of infectious keratitis but also to maintain a high clinical suspicion 
for Acanthamoeba keratitis because an early diagnosis may lead to a better visual outcome 
(Tanhehco & Colby, 2010). The use of surfactant cleaner has been shown to be an effective 
way of removing Acanthamoeba trophozoites and cysts (Kilvington, 1993). In the light of 
these findings further research into the types of disinfectant used by patients with 
Acanthamoeba keratitis is required, with a view to calculating the relative risks of different 
lens type and disinfectant combinations. This series also show the importance of the fact that 
contact lens practitioners should ensure at the time of prescribing lenses that patients have 
understood all the disinfectant procedures (Illingworth et al., 1995). Gray et al. suggest 
leaving contact lens case open to dry air after heat disinfection. If hydrogen peroxide 
disinfection is the preferred solution, one has to use a two step hydrogen peroxide system. It 
is necessary to call one’s attention to wash hands properly before handling contact lens cases 
and what is more important is to avoid homemade saline. The contact lens case should be 
replaced regularly. Nowadays the use of more frequently disposable contact lenses is highly 
recommended (Gray et al., 1995). Also the rub and rinse step should be mentioned as the 
critical part of the disinfection that may reduce significantly the microbiological load (Shih 
et al., 1985). Detailed education of contact lens wearers concerning of the entire disinfection 
procedure could reduce the incidence of Acanthamoeba keratitis further on. There is a 
persistent need to educate contact lens wearers continuously about the possible risk factors 
of Acanthamoeba keratitis, and since the frequency of Acanthamoeba keratitis appears to be 
largely determined by the ever changing trends in contact lens use, continued monitoring is 
indicated (Radford et al., 1998). All of the eye care practitioners have to call attention of all 
contact lens users to aware the wearing of soft contact lenses in case of swimming so as to 
reduce the number of patients with Acanthamoeba keratitis (Kaji et al., 2005; Kettesy et al., 
2010). If even a soft contact lens wearer wants to swim, then daily disposable contact lens 
and swimming spectacles should be used. 
4. Conclusion 
Acanthamoebic keratitis, first reported by Nagington et al. in Great Britain and by Jones et 
al. in the United States, is a painful progressive sight-threatening corneal disease. The 
infection is a rather frequently occurring disease all over the world which can still cause 
serious or even total loss of vision despite improved diagnostic and therapeutic options. 
Acanthamoeba spp. are among the most prevalent protozoa found in the environment. They 
are distributed worldwide and have been isolated from soil, dust, air, natural and treated 
water, seawater, swimming pools, sewage, sediments, air-conditioning units, drinking water 
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treatment plants, bottled water, dental treatment units, hospitals and dialysis units, eyewash 
stations, and contact lenses and lens cases and as contaminants in bacterial, yeast, and 
mammalian cells. It mainly affects contact lens wearers with poor hygiene. In non contact 
lens wearers history of trauma in a garden is a risk factor. Patients’ ages range from 4 to 64 
years, with a mean age of 30 years, with no difference in genders. Infection usually affects 
only one eye, although it is occasionally bilateral. Most patients complain of symptoms of 
photophobia, pain, and tearing. The earliest signs may be non-specific and may take the 
form of epithelial micro erosions, irregularities, opacities or microcystic oedema, often with 
patchy anterior stromal infiltrates. There may be no fluorescein staining at the onset. 
Commonly, there is a dendriform keratitis that is often initially treated as herpes simplex 
infection. A ring infiltrate, usually with an overlying epithelial defect, is commonly seen. 
The ring may be incomplete, or occasionally it is double and concentric. The importance of 
early diagnosis cannot be overemphasized. We have to consider Acanthamoeba keratitis 
when symptoms associated with trauma especially involving vegetable matter or exposure 
to contaminated water, such as lake-, sea-, or spring water are mentioned. Acanthamoebic 
keratitis has to be differentiated from bacterial or fungal or herpes simplex virus keratitis. 
Diagnosis may be achieved by using different methods, including non invasive confocal 
microscopy, staining corneal scrapings with acridine orange, corneal scrapes or corneal 
biopsy specimens onto no nutrient agar containing E. coli., cytological various staining 
methods, like indirect immunofluorescent-antibody assay, polymerase chain reaction (PCR)-
based method. The goals of medical therapy in Acanthamoeba keratitis include the 
eradication of viable cysts and trophozoites and rapid resolution of the associated 
inflammatory response. There is no single drug capable of eliminating the infection 
therefore drug combinations have been suggested as a treatment regimen. There are 
currently no drugs that are effective as monotherapy in Acanthamoeba keratitis, hence 
combinations are suggested. Acanthamoeba trophozoites are sensitive to most available 
chemotherapeutic agents (antibiotics, antiseptics, antifungals, antiprotozoals including 
metronidazole, antiviral, and antineoplastic agents). The diamidines and biguanides are 
currently the most effective cysticidal antiamoebics. With respect to the severity of the 
disease as well as the complications accompanying it there is a range of surgical methods to 
choose from. Corneal abrasion, cryosurgery, deep lamellar keratectomy with a conjunctival 
flap, amnion membrane transplantation, keratoplasty, deep lamellar keratoplasty. In some 
cases enucleation or evisceration is needed, because of severe inflammation, infection or 
secondary glaucoma. Antiamoebic therapy should be used before surgery and be continued 
postoperatively using drugs and doses that will minimize or avoid signs of toxicity. PHMB 
0.02% has low clinical toxicity in most patients and is clinically less than that with either of 
the diamidines. We use PHMB 0.02% 6 to 8 times daily immediately after surgery, with an 
adequate level of topical steroid to control inflammation. This should be continued for at 
least 3 weeks while results of culture of the host keratectomy specimen are awaited. If viable 
organisms are cultured it is prudent to continue antiamoebic therapy 4 times daily while 
high-doses of steroids are needed usually for 6 months after surgery, as recurrent 
Acanthamoeba keratitis has occurred up to 3 months after an initially successful transplant. 
If culture of the excised host cornea is negative after 3 weeks we assume that most viable 
amoebae have been treated, and the topical antiamoebic therapy is reduced to 4 times daily 
and stopped after 1 month. 
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Between 2001 and 2006 we treated 11 patients with Acanthamoeba keratitis. The patients 
were all soft contact lens wearers. The right eye was affected in six and the left in five cases. 
82% of the infections occurred in the summer period between June and September. Beside 
long-lasting conservative treatment perforating keratoplasty was performed nearly in half of 
the cases.  
In every case the infection was caused by poor and improper contact lens hygiene. All lenses 
involved were hydrogel soft lenses: 1 daily, 4 monthly and 1 yearly disposable. None of the 
lenses were extended or continuous wear. The half of the patients got the lenses from 
opticians, the other half from ophthalmologists. 
Significant visual decrease was seen in almost all cases. Slit lamp examination showed 
corneal infiltration in 2 cases, ring infiltration (Fig. 1. and 2.) in 3 cases and corneal abscess in 
1 case. The diagnosis of Acanthamoeba keratitis was based on corneal scraping in 2 cases, 
histology in 2 cases, and clinical findings in 2 cases.   
Treatment started with antiamoebic agents in all patients: dibromopropamide or 
propamidin and polihexamethilen biguanidine was administered hourly in the first week, 
and then 5 times/day for at least 6 months. All patients were administered antibiotic drops 
5 times a day for 2 weeks. We used steroid or non-steroid agents against the inflammation in 
seven cases.  
In one case we performed corneal abrasion, but as it proved ineffective we followed it up 
with perforating keratoplasty. 
Altogether penetrating keratoplasty was performed in six cases. In four cases keratoplasty 
was performed as an emergency (because of descemetocele) to save the eyeball, in two cases 
the operations were scheduled for visual rehabilitation.  
All keratoplasties were perforating (penetrating), and central. All surgical procedures were 
done by two experienced surgeons. All cases were performed under retrobulbar 
anaesthesia. The trephination was performed with modified Geuder trephines. Donor 
corneas were obtained from the Eye Bank of our department. Only grafts with an 
endothelial cell count above 2000 cells/mm² were used. Graft fixation was performed in all 
cases with running nylon 10/0 sutures. We have had no intraoperative complications.  
At the last follow up visit the average visual acuity was 0.43. In 3 cases it was only light 
perception, but the other 3 patients had very good corrected visual acuity (0.7-1.0). 
In the emergency cases the visual acuity was much worse (light perception in 3 cases and 0.9 
in one case, respectively), then in the proposed cases (0.7 and 1.0). In 5 cases the cornea graft 
was clear, rejection and decompensation developed only in one case.  
Emergency keratoplasty is often the only possible intervention to prevent complete and 
irreversible vision loss in some cases. The main indications for this urgent surgical 
procedure are corneal perforations or imminent perforations, maintaining the integrity of 
the eyeball. Performing penetrating keratoplasty before scleral or peripheral corneal 
extension can minimize the risk of recurrence and poor outcome. Clear graft survival is 
lower if penetrating keratoplasty was performed during the acute, inflamed period of the 
disease compared to much higher clear graft survival when penetrating keratoplasty was 
performed in a quiet state of the disease. Perforating keratoplasty for visual restoration after 
resolution of Acanthamoeba keratitis in quiet eyes that are judged cyst-free by preoperative 
confocal microscopy appears to have an excellent long-term prognosis. Waiting at least 3 
months after the discontinuation of medical therapy also appears helpful to rule out latent 
infection because of cyst reactivation and to allow the active inflammation to cease. 
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Acanthamoeba keratitis is a potentially blinding condition of the eye, and any steps toward 
prevention of this disease are encouraged. For prevention contact lens wearers are 
recommended to use daily disposable contact lenses to eliminate the contact lens case as a 
reservoir for Acanthamoeba. Hydrogen peroxide cleaning solutions are preferred over the 
more common multipurpose solutions. Planned replacement of contact lens storage cases 
may also help to reduce contamination. The rub and rinse step should be mentioned as the 
critical part of the disinfection. Detailed education of contact lens wearers concerning the 
entire disinfection procedure could minimize the incidence of Acanthamoeba keratitis 
further on. All of the eye care practitioners have to call attention of all contact lens users to 
aware the wearing of soft contact lenses in case of swimming so as to diminish the number 
of patients with Acanthamoeba keratitis. If even a soft contact lens wearer wants to swim, 
then daily disposable contact lens and swimming spectacles should be applied. 
5. References 
Amoils SP. & Heney C. (1999) Acanthamoeba keratitis with live isolates treatet with 
cryosurgery and Fluconazole. Am. J. Ophthalmol, Vol. 127, No. 6, pp. 718-720 
Awwad ST., Parmar DN., Heilman M., Bowman RW., McCulley JP.& Cavanagh HD. (2005) 
Results of penetrating keratoplasty for visual rehabilitation after acanthamoeba 
keratitis. Am J Ophthalmol, Vol. 140, No. 6, pp. 1080-1084 
Bacon AS., Frazer DG., Dart JKG., Mathelson M., Ficker LA. &Wright P.(1993) A review of 
72 consecutive cases of Acanthamoeba keratitis. 1984-1992. Eye, Vol. 7, pp. 719-725   
Beattie TK., Tomlinson A., & Mc Fadyen AK. (2006) Attachment of Acanthamoeba to first- 
and second-generation silicone hydrogel contact lenses. Ophthalmology, Vol. 113, 
No. 1, pp. 117-125  
Beattie TK., Tomlinson A., McFadyen AK. Seal DV. & Grimason AM. (2003) Enhanced 
attachment of Acanthamoeba to extended-wear silicone hydrogel contact lenses. 
Ophthalmology, Vol. 110, No. 4, pp. 765-771  
Bourcier T., Patteau F., Borderie V., Baudrimont M., Rondeau N., Bonnel S., Chaumeil C.& 
Laroche L. (2004) Amniotic membrane transplantation for the treatment severe 
acanthamoeba keratitis. Can J Ophthalmol, Vol. 39, No. 6, pp. 621-631 
Chynn EW., Lopez MA., Pavan-Langston D. & Talamo JH. (1995) Acanthamoeba keratitis 
Contact lens and noncontact lens characteristic. Ophthalmology, Vol. 102, No.9, pp. 
1369-1373 
Clarke DW. &  Niederkorn J. (2006) The pathophysiology of Acanthamoeba keratitis. Trends 
Parasitol, Vol. 22, No. 4, pp. 175-180  
Cremona G., Carrasco MA., Tytiun A.&Cosentino MJ. (2002) Treatment of advanced 
Acanthamoeba keratitis with deep lamellar keratectomy and conjunctival flap. 
Cornea, Vol.  21, No. 7, pp. 705-708 
Dart JK., Saw VP., & Kilvington S. (2009) Acanthamoeba keratitis: diagnosis and treatment 
update 2009. Am J Ophthalmol, Vol. 148, No. 4 pp. 487-499 
Dejaco-Ruhswurm I., Scholz U., Hanselmayer G. & Skorpik C. (2001) Contact lens induced 
keratitis associated with contact lens wear. Acta Ophthalmol Scand, Vol. 79, pp. 479-483 
Dunand VA., Hammer SM., Rossi R., Poulin M., Albrecht MA., Doweiko JP., DeGirolami 
PC., Coakley E., Piessens E. & Wanke CA. (1997) Parasitic sinusitis and otitis in 
www.intechopen.com
 
Keratoplasties – Surgical Techniques and Complications 
 
50
patients infected with human immunodeficiency virus: report of five cases and 
review. Clin Infect Dis, Vol. 25, pp. 267-272  
Ficker LA., Kirkness C.& Wright P. (1993) Prognosis for keratoplasty in Acanthamoeba 
keratitis. Ophthalmology, Vol. 100, No. 1, pp. 105-110  
Gordon VR., Asem EK.,  Vodkin MH., & McLaughlin GL. (1993) Acanthamoeba binds to 
extracellular matrix proteins in vitro. Invest Ophthalmol Vis Sci, Vol. 34, pp. 658–662 
Gray TB., Curson R.M., Sherwarn JF.Rose PR. (1995) Acanthamoeba, bacterial, and fungal 
contamination of contact lens storage cases. Br J Ophthalmol, Vol 79, pp. 601-605  
Gullett J., Mills J., Hadley K., Podemski B., Pitts L. & Gelber R. (1979) Disseminated 
granulomatosus Acanthamoeba infection presenting as an unusual skin lesion. Am 
J Med, Vol. 67 pp. 891-896  
Hahn TW., O’Brien TP., Sah WJ.& Kim JH. (1998) Acridine orange staining for rapid 
diagnosis of Acanthamoeba keratitis. Jpn J Ophthalmol, Vol. 42, No. 2, pp. 108-114  
Hurt M., Niederkorn J., & Alizadeh H. (2003) Effects of mannose on Acanthamoeba 
castellanii proliferation and cytolytic ability to corneal epithelial cells. Invest 
Ophthalmol Vis Sci, Vol. 44, No. 8, pp. 3424-3431  
Illingworth CD. & Cook SD.  (1998) Acanthamoeba keratitis. Surv Ophthalmol, Vol. 42, No.6, 
pp. 493-508 
Illingworth CD., Cook SD., Karabatsas CH. & Easty DL. (1995) Acanthamoeba keratitis risk 
factor and outcome. Br J Ophthalmol, Vol. 79, pp. 1078-1082  
Jones BR., Visvesvara GS., & Robinson NM. (1975) Acanthamoeba polyphaga keratitis and 
Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol 
Soc UK, Vol. 95, pp. 221-232  
Kaji Y., Hu B., Kawana K., & Oshika T. (2005) Swimming with soft contact lenses: danger of 
acanthamoeba keratitis. Lancet Infect Dis.Vol.5, No. 6, pp.392 
Kashiwabuchi RT., de Freitas D., Alvarenga LS., Vieira L., Contarini P., Sato E., Foronda A. 
& Hofling-Lima AL. (2008) Corneal graft survival after therapeutic keratoplasty for 
Acanthamoeba keratitis. Acta Ophthalmol, Vol.86, No. 6, pp. 666-669 
Kettesy B., Módis L., Komár T., Berta A. (2010) Acanthamoeba keratitis in patients with 
contact lens wear in the Department of Ophthalmology in Debrecen]. 
Ophthalmologe. Vol. 107, No. 6 pp.537-542  
Khan NA. (2001) Pathogenicity, morphology, and differentation of Acanthamoeba. Curr 
Microbiol, Vol. 43, No. 6, pp. 391-395 
Khan NA., Jarroll EL. & Paget TA. (2001) Acanthamoeba can be differentiated by the 
polymerase chain reaction and simple planting assay. Curr Microbiol, Vol. 43, No. 3, 
pp. 204-208  
Kilvington S. (1993) Acanthamoeba trophozoite and cyst adherence to four types of soft 
contact lens and removal by cleaning agents. Eye, Vol. 7, pp. 535-538 
Kilvington S., Gray T., Dart J., Moret N., Beechiing JR., Frazer DG. & Matheson M. (2004) 
Acanthamoeba keratitis: The role of domestic tap water contamination in the 
United Kingdom. Invest Ophthalmol Vis Sci, Vol. 45, No. 1, pp. 165-169 
Kim JS., Kim JC., Na BK.,Jeong JM. &Song CY. (2000) Amniotic membrane patching 
promotes healing and inhibits proteinase activity on wound healing following 
acute corneal alkali burn. Exp Eye Res, Vol, 70, pp. 329-337 
Kitzmann AS., Goins KM., Sutphin JE.& Wagoner MD. (2009) Keratoplasty for treatment of 
Acanthamoeba keratitis. Ophthalmology, Vol.116, No. 5, pp. 864-869 
www.intechopen.com
 
Keratoplasty in Contact Lens Related Acanthamoeba Keratitis 
 
51 
Lema I., Rodríguez-Ares MT., Gómez-Torreiro M. & Penalver MD. (2001) Adherence of 
Acanthamoeba to unworn conventional and disposable soft contact lenses. Cornea, 
Vol. 20, No. 6, pp. 635-638  
Maier P., Böhringer D.& Reinhard T. (2007) Clear graft survival and immune reactions 
following emergency keratoplasty. Graefes Arch Clin Exp Ophthalmol, Vol. 245, No. 
3, pp.351-359 
Marciano-Cabral F., & Cabral G. (2003) Acanthamoeba ssp. as agent of disease in humans. 
Clin Microbiol Rev, Vol. 16, No. 2, pp. 273-307  
Martinez AJ., Guerra AE., Garcia-Tamayo J., Céspedes G., Gonzalez-Alfonzo JE.&Visvesvara 
GS. (1994) Granulomatosus amoebic encephalitis: a review and report of a 
spontaneous case from Venezuela. Acta Neuropathol, Vol 87, No.4, pp. 430-434  
Mc-Clellan K., Howard K., Niederkorn JY., & Alizadeh H. (2001) Effect of seroid on 
Acanthamoeba cyst and trophosoites. Invest Ophthalmol Vis Sci, Vol. 42, No. 12 pp. 
2885-2893 
Nagington J., Watson PG., Playfair TJ., McGill J., Jones BR. & Steele AD. (1974) Amoebic 
infection of the eye. Lancet, pp. 1537-1540  
Nguyen TH., Weisenthal RW., Florakis GJ., Reidy JJ.,Gaster RN., & Tom D. (2010) 
Penetrating Keratoplasty in Active Acanthamoeba Keratitis. Cornea, Vol. 29, No. 9, 
pp. 1000-1004 
Nwachuku N. & Gerba CP (2004) Health Effects of Acanthamoeba spp. and its potential for 
waterborne transmission. Rev Environ Contam Toxicol, Vol. 180, pp. 93-131  
Parthasarathy A. & Tan DT. (2007) Deep lamellar keratoplasty for acanthamoeba keratitis. 
Cornea, Vol. 26, No. 8, pp. 1021-1023 
Por YM., Mehta JS., Chua JL., Koh TH., Khor WB., Fong AC., Lim JW., Heng WJ., Loh RS., 
Lim L. & Tan DT. (2009) Acanthamoeba keratitis associated with contact lens wear 
in Singapore. Am J Ophthalmol, Vol. 148, No. 1, pp. 7-12 
Qian Y., Meisler DM., Langston RH.& Jeng BH. (2010) Clinical experience with 
Acanthamoeba keratitis at the cole eye institute, 1999-2008. Cornea, Vol. 29, No. 9, 
pp. 1016-1021 
Radford CF., Bacon AS., Dart JKG., & Minassian DC. (1995) Risk factors for acanthamoeba 
keratitis contact lens users: a case control study. BMJ, Vol. 310 pp.1567–1570 
Radford CF., Lehmann OJ., & Dart JKG. (1998) Acanthamoeba keratitis: multicentre survey 
in England 1992–1996. Br J Ophthalmol, Vol. 82j pp.1387–1392 
Radford CF., Minassian DC., & Dart JKG. (2002) Acanthamoeba keratitis in England and 
Wales: incidence, outcome, and risk factors. Br J Ophthalmol, Vol. 86j pp. 536–542 
Reinhard T., &  Sundmacher R.  (2000) Klinik und Therapie der Akantamöbenkeratitis. 
Ophthalmologe, Vol. 97, pp. 446-459 
Seal DV. 2003 Acanthamoeba keratitis update-incidence, molecular epidemiology and new 
drugs for treatment. Eye, Vol.17, pp.  893-905  
Seal DV., Kirkness CM., Bennett HGB. & Peterson M. (1999) Acanthamoeba keratitis in 
Scotland: risk factors for contact lens wearers. Contact Lens Anterior Eye, Vol. 22, No. 
2, pp. 58-68 
Sharma S., Garg P. & Rao GN. (2000) Patient characteristics, diagnosis, and treatment of 
non-contact lens releated Acanthamoeba keratitis. Br J Ophthalmol, Vol. 84, pp. 
1103-1108 
www.intechopen.com
 
Keratoplasties – Surgical Techniques and Complications 
 
52
Shi W., Liu M., Gao H., Li S. & Xie L. (2009) Perioperative treatment and prognostic factors 
for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical 
treatment. Graefes Arch Clin Exp Ophthalmol, Vol. 247, No. 10, pp. 1383-1388  
Shih KL., Hu J.& Sibley MJ. (1985) The microbiological benefit of cleaning and rinsing of 
contact lenses. Int Contact Lens Clin; Vol. 12. pp.235–242. 
Stehr-Green JK., Bailey TM., & Visvesvara GS. (1989) The epidemiology of Acanthamoeba 
keratitis in the United States. Am J Ophthalmol, Vol. 107, No. 4, pp. 331–336 
Taenaka N, Fukuda M, Hibino T, Kato Y, Arimura E, Ishii Y, & Shimomura Y. (2007) 
Surgical therapies for Acanthamoeba keratitis by phototherapeutic keratectomy 
and deep lamellar keratoplasty. Cornea,  Vol. 26, No. 7, pp. 876-879 
Tanhehco T.& Colby K. (2010) The clinical experience of Acanthamoeba keratitis at a tertiary 
care eye hospital. Cornea,Vol.29, No.9, pp.1005-1010 
Wilhelmus KR., Jones DB., Matoba AY., Hamill MB., Pflugfelder  SC., & Weikert MP.Bilateral 
acanthamoeba keratitis. Am J Ophthalmol, 2008 Vol. 145, No. 2, pp. 193-197 
www.intechopen.com
Keratoplasties - Surgical techniques and complications
Edited by Dr. Luigi Mosca
ISBN 978-953-307-809-0
Hard cover, 134 pages
Publisher InTech
Published online 18, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
In this book, the authors illustrate different therapeutic and surgical approaches to treating various corneal
pathologies. This edition in electronic format allows universal access to everybody regardless of the time of
day or setting, portability, and speed of information access. Such features show more feasibility for all readers
and reduce the time necessary for research. This book will be a good tool for students as well as specialists
working in the field of corneal transplantation, to improve their knowledge of treatment of corneal disease.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Beata Kettesy, Laszlo Modis Jr., Andras Berta and Adam Kemeny-Beke (2012). Keratoplasty in Contact Lens
Related Acanthamoeba Keratitis, Keratoplasties - Surgical techniques and complications, Dr. Luigi Mosca
(Ed.), ISBN: 978-953-307-809-0, InTech, Available from: http://www.intechopen.com/books/keratoplasties-
surgical-techniques-and-complications/keratoplasty-in-contact-lens-related-acanthamoeba-keratitis
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
